<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p169" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_169{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_169{left:306px;bottom:30px;}
#t3_169{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_169{left:346px;bottom:30px;}
#t5_169{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_169{left:517px;bottom:30px;}
#t7_169{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_169{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_169{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_169{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_169{left:35px;bottom:777px;letter-spacing:0.16px;word-spacing:0.02px;}
#tc_169{left:35px;bottom:754px;letter-spacing:0.05px;word-spacing:-0.79px;}
#td_169{left:207px;bottom:761px;letter-spacing:0.61px;}
#te_169{left:220px;bottom:754px;letter-spacing:0.08px;word-spacing:-1.13px;}
#tf_169{left:330px;bottom:761px;letter-spacing:-0.01px;}
#tg_169{left:348px;bottom:754px;letter-spacing:0.2px;word-spacing:-0.64px;}
#th_169{left:35px;bottom:731px;letter-spacing:-0.18px;}
#ti_169{left:120px;bottom:738px;letter-spacing:-0.01px;}
#tj_169{left:143px;bottom:731px;letter-spacing:0.06px;word-spacing:0.13px;}
#tk_169{left:35px;bottom:707px;letter-spacing:0.16px;word-spacing:0.03px;}
#tl_169{left:35px;bottom:684px;letter-spacing:0.17px;word-spacing:0.02px;}
#tm_169{left:35px;bottom:661px;letter-spacing:0.13px;word-spacing:0.06px;}
#tn_169{left:35px;bottom:638px;letter-spacing:0.06px;word-spacing:0.12px;}
#to_169{left:35px;bottom:614px;letter-spacing:0.16px;word-spacing:0.02px;}
#tp_169{left:35px;bottom:591px;letter-spacing:0.09px;word-spacing:0.1px;}
#tq_169{left:35px;bottom:552px;letter-spacing:0.14px;word-spacing:0.04px;}
#tr_169{left:35px;bottom:529px;letter-spacing:0.11px;word-spacing:0.07px;}
#ts_169{left:35px;bottom:506px;letter-spacing:0.11px;word-spacing:0.08px;}
#tt_169{left:35px;bottom:482px;letter-spacing:0.16px;word-spacing:0.03px;}
#tu_169{left:35px;bottom:459px;letter-spacing:0.06px;word-spacing:-0.07px;}
#tv_169{left:35px;bottom:436px;letter-spacing:0.01px;word-spacing:-0.44px;}
#tw_169{left:380px;bottom:444px;letter-spacing:-0.01px;}
#tx_169{left:402px;bottom:436px;letter-spacing:0.18px;word-spacing:-0.81px;}
#ty_169{left:35px;bottom:413px;letter-spacing:0.11px;word-spacing:0.08px;}
#tz_169{left:35px;bottom:390px;letter-spacing:0.04px;word-spacing:0.14px;}
#t10_169{left:35px;bottom:366px;letter-spacing:0.09px;word-spacing:-0.36px;}
#t11_169{left:35px;bottom:343px;letter-spacing:0.06px;word-spacing:-0.99px;}
#t12_169{left:35px;bottom:320px;letter-spacing:0.07px;word-spacing:0.21px;}
#t13_169{left:35px;bottom:297px;letter-spacing:0.14px;word-spacing:0.04px;}
#t14_169{left:35px;bottom:256px;letter-spacing:0.09px;word-spacing:-1.03px;}
#t15_169{left:35px;bottom:233px;letter-spacing:-0.05px;word-spacing:0.23px;}
#t16_169{left:164px;bottom:233px;letter-spacing:0.16px;word-spacing:-1.2px;}
#t17_169{left:386px;bottom:233px;letter-spacing:0.17px;word-spacing:-1.22px;}
#t18_169{left:431px;bottom:233px;letter-spacing:0.16px;word-spacing:-0.59px;}
#t19_169{left:35px;bottom:210px;letter-spacing:0.12px;word-spacing:-1.01px;}
#t1a_169{left:439px;bottom:217px;}
#t1b_169{left:483px;bottom:210px;letter-spacing:-0.15px;word-spacing:-0.91px;}
#t1c_169{left:35px;bottom:187px;letter-spacing:0.02px;word-spacing:0.17px;}
#t1d_169{left:35px;bottom:163px;letter-spacing:0.08px;word-spacing:-0.75px;}
#t1e_169{left:35px;bottom:140px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1f_169{left:477px;bottom:148px;}
#t1g_169{left:522px;bottom:140px;}
#t1h_169{left:35px;bottom:117px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1i_169{left:35px;bottom:94px;letter-spacing:0.04px;word-spacing:-1.09px;}
#t1j_169{left:35px;bottom:71px;letter-spacing:0.12px;word-spacing:-0.62px;}
#t1k_169{left:618px;bottom:777px;letter-spacing:0.01px;word-spacing:0.17px;}
#t1l_169{left:1045px;bottom:785px;letter-spacing:-0.01px;}
#t1m_169{left:1068px;bottom:777px;letter-spacing:-0.18px;word-spacing:0.37px;}
#t1n_169{left:618px;bottom:754px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1o_169{left:618px;bottom:731px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1p_169{left:618px;bottom:707px;letter-spacing:0.05px;}
#t1q_169{left:675px;bottom:715px;letter-spacing:-0.01px;}
#t1r_169{left:698px;bottom:707px;letter-spacing:0.19px;word-spacing:-0.01px;}
#t1s_169{left:618px;bottom:684px;letter-spacing:0.14px;word-spacing:0.04px;}
#t1t_169{left:618px;bottom:661px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1u_169{left:618px;bottom:638px;letter-spacing:0.06px;word-spacing:0.12px;}
#t1v_169{left:618px;bottom:614px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1w_169{left:618px;bottom:591px;letter-spacing:0.03px;word-spacing:0.16px;}
#t1x_169{left:618px;bottom:568px;letter-spacing:0.07px;word-spacing:-1.11px;}
#t1y_169{left:860px;bottom:576px;letter-spacing:-0.11px;}
#t1z_169{left:903px;bottom:568px;letter-spacing:0.07px;word-spacing:-0.71px;}
#t20_169{left:618px;bottom:545px;letter-spacing:0.14px;word-spacing:0.04px;}
#t21_169{left:618px;bottom:506px;letter-spacing:0.1px;word-spacing:0.09px;}
#t22_169{left:618px;bottom:482px;letter-spacing:0.12px;word-spacing:-0.17px;}
#t23_169{left:618px;bottom:459px;letter-spacing:0.1px;word-spacing:-1.14px;}
#t24_169{left:618px;bottom:436px;letter-spacing:0.13px;word-spacing:0.06px;}
#t25_169{left:618px;bottom:413px;letter-spacing:-0.02px;word-spacing:0.2px;}
#t26_169{left:618px;bottom:390px;letter-spacing:0.1px;word-spacing:0.08px;}
#t27_169{left:618px;bottom:366px;letter-spacing:0.06px;word-spacing:0.12px;}
#t28_169{left:618px;bottom:343px;letter-spacing:0.14px;word-spacing:0.06px;}
#t29_169{left:618px;bottom:320px;letter-spacing:0.04px;word-spacing:0.15px;}
#t2a_169{left:618px;bottom:297px;letter-spacing:0.13px;word-spacing:0.06px;}
#t2b_169{left:618px;bottom:273px;letter-spacing:0.21px;word-spacing:-0.33px;}
#t2c_169{left:618px;bottom:250px;letter-spacing:0.13px;word-spacing:0.06px;}
#t2d_169{left:618px;bottom:227px;letter-spacing:0.18px;word-spacing:0.01px;}
#t2e_169{left:618px;bottom:204px;letter-spacing:0.07px;word-spacing:0.12px;}
#t2f_169{left:618px;bottom:163px;letter-spacing:0.15px;word-spacing:0.04px;}
#t2g_169{left:618px;bottom:140px;letter-spacing:0.05px;word-spacing:0.14px;}
#t2h_169{left:618px;bottom:117px;letter-spacing:0.14px;word-spacing:0.06px;}
#t2i_169{left:618px;bottom:94px;letter-spacing:0.03px;word-spacing:0.16px;}
#t2j_169{left:618px;bottom:71px;letter-spacing:0.11px;word-spacing:-0.75px;}
#t2k_169{left:875px;bottom:78px;letter-spacing:0.06px;}
#t2l_169{left:942px;bottom:71px;letter-spacing:0.12px;word-spacing:0.07px;}
#t2m_169{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_169{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_169{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_169{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_169{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_169{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_169{font-size:11px;font-family:ArialMT_5tg;color:#000;}
.s6_169{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s7_169{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts169" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg169Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg169" style="-webkit-user-select: none;"><object width="1210" height="935" data="169/169.svg" type="image/svg+xml" id="pdf169" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_169" class="t s0_169">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_169" class="t s1_169">© </span>
<span id="t3_169" class="t s0_169">(NCCN </span>
<span id="t4_169" class="t s1_169">© </span>
<span id="t5_169" class="t s0_169">), All rights reserved. NCCN Guidelines </span>
<span id="t6_169" class="t s1_169">® </span>
<span id="t7_169" class="t s0_169">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_169" class="t s2_169">NCCN Guidelines Version 4.2024 </span>
<span id="t9_169" class="t s2_169">Head and Neck Cancers </span>
<span id="ta_169" class="t s3_169">MS-28 </span>
<span id="tb_169" class="t s4_169">disease, elective neck dissection should be considered in those with T2 </span>
<span id="tc_169" class="t s4_169">tumors (as per AJCC 7 </span>
<span id="td_169" class="t s5_169">th </span>
<span id="te_169" class="t s4_169">edition staging </span>
<span id="tf_169" class="t s5_169">390 </span>
<span id="tg_169" class="t s4_169">), given their risk of occult nodal </span>
<span id="th_169" class="t s4_169">metastasis. </span>
<span id="ti_169" class="t s5_169">396 </span>
<span id="tj_169" class="t s4_169">This analysis also showed that disease recurrence rates </span>
<span id="tk_169" class="t s4_169">were greater in patients with cT1–2, N0 disease who were observed, </span>
<span id="tl_169" class="t s4_169">compared to those who underwent elective neck dissection (OR, 4.18; </span>
<span id="tm_169" class="t s4_169">95% CI, 2.78–6.28), although the studies included in this analysis were </span>
<span id="tn_169" class="t s4_169">significantly heterogeneous. It is unclear at this time what the impact will </span>
<span id="to_169" class="t s4_169">be of the inclusion of depth of invasion in oral cavity staging on </span>
<span id="tp_169" class="t s4_169">management of the N0 neck. </span>
<span id="tq_169" class="t s4_169">The role of elective neck dissection for early-stage mucosal lip cancer is </span>
<span id="tr_169" class="t s4_169">also the subject of considerable debate. Historically, elective neck </span>
<span id="ts_169" class="t s4_169">dissection was limited to those with T3 or T4 disease, although this </span>
<span id="tt_169" class="t s4_169">preference predates the inclusion of mucosal lip specifically into the oral </span>
<span id="tu_169" class="t s4_169">cavity. Depth of invasion is a risk factor for nodal metastasis in lip cancer, </span>
<span id="tv_169" class="t s4_169">but mucosal lip was not specifically examined. </span>
<span id="tw_169" class="t s5_169">397 </span>
<span id="tx_169" class="t s4_169">Depth of invasion should </span>
<span id="ty_169" class="t s4_169">be used to determine treatment of the neck in early-stage mucosal lip </span>
<span id="tz_169" class="t s4_169">cancer, similar to how other early-stage oral cancers are treated with </span>
<span id="t10_169" class="t s4_169">elective neck dissection (supraomohyoid with special attention being paid </span>
<span id="t11_169" class="t s4_169">to submental and perifacial nodes) being indicated for depth of invasion &gt;4 </span>
<span id="t12_169" class="t s4_169">mm or for T2 lesions. Like other oral cavity sites, sentinel mapping may </span>
<span id="t13_169" class="t s4_169">also be considered. </span>
<span id="t14_169" class="t s4_169">Sentinel lymph node biopsy (SLNB) may be used to identify occult cervical </span>
<span id="t15_169" class="t s4_169">metastases (see </span><span id="t16_169" class="t s6_169">Sentinel Lymph Node Biopsy </span><span id="t17_169" class="t s4_169">in the </span><span id="t18_169" class="t s6_169">Principles of Surgery </span>
<span id="t19_169" class="t s4_169">in the NCCN Guidelines for Head and Neck Cancers). </span>
<span id="t1a_169" class="t s5_169">398-404 </span>
<span id="t1b_169" class="t s4_169">Occult cervical </span>
<span id="t1c_169" class="t s4_169">metastases are not common in patients with early-stage lip cancer, but </span>
<span id="t1d_169" class="t s4_169">SLNB has been shown to be feasible and effective in patients who may be </span>
<span id="t1e_169" class="t s4_169">at high risk of metastases based on tumor size and depth. </span>
<span id="t1f_169" class="t s5_169">405-407 </span>
<span id="t1g_169" class="t s4_169">A </span>
<span id="t1h_169" class="t s4_169">systematic review including 98 observational or retrospective studies </span>
<span id="t1i_169" class="t s4_169">showed sensitivity and specificity values of 82.7% (95% CI, 80.4%–84.8%) </span>
<span id="t1j_169" class="t s4_169">and 98.1% (95% CI, 97.5%–98.6%), respectively, for detection of cervical </span>
<span id="t1k_169" class="t s4_169">metastases in patients with cT1–2 N0 oral cavity cancer. </span>
<span id="t1l_169" class="t s5_169">408 </span>
<span id="t1m_169" class="t s4_169">SLNB and </span>
<span id="t1n_169" class="t s4_169">neck dissection were compared in one randomized phase III multicenter </span>
<span id="t1o_169" class="t s4_169">equivalence trial, which included 307 patients with cT1–2 N0 oral cavity </span>
<span id="t1p_169" class="t s4_169">cancer. </span>
<span id="t1q_169" class="t s5_169">409 </span>
<span id="t1r_169" class="t s4_169">There were no statistically significant differences between the </span>
<span id="t1s_169" class="t s4_169">study arms for recurrence-free survival, DSS, and OS. Results from an </span>
<span id="t1t_169" class="t s4_169">ongoing NRG trial (NCT04333537) may also provide clearer direction in </span>
<span id="t1u_169" class="t s4_169">this area; however, the estimated primary completion date for this trial is </span>
<span id="t1v_169" class="t s4_169">May 2031. Some diagnostic agents for use in SLNB in patients with </span>
<span id="t1w_169" class="t s4_169">squamous cell carcinoma of the oral cavity have been evaluated (eg, </span>
<span id="t1x_169" class="t s4_169">technetium Tc99m tilmanocept), </span>
<span id="t1y_169" class="t s5_169">410,411 </span>
<span id="t1z_169" class="t s4_169">but the data are currently too limited </span>
<span id="t20_169" class="t s4_169">for the panel to recommend a specific agent. </span>
<span id="t21_169" class="t s4_169">Postsurgical adjuvant treatment options depend on whether adverse </span>
<span id="t22_169" class="t s4_169">pathologic features are present. Close or positive margins on the primary </span>
<span id="t23_169" class="t s4_169">specimen and the presence of extranodal extension (ENE) in lymph nodes </span>
<span id="t24_169" class="t s4_169">are indications for systemic therapy with radiation. The role of perineural </span>
<span id="t25_169" class="t s4_169">invasion, vascular invasion, and lymphatic invasion in directing adjuvant </span>
<span id="t26_169" class="t s4_169">therapy are less established but are usually considered indications for </span>
<span id="t27_169" class="t s4_169">adjuvant radiotherapy. For patients with resected oral cavity cancers who </span>
<span id="t28_169" class="t s4_169">have the adverse pathologic features of extranodal extension with or </span>
<span id="t29_169" class="t s4_169">without a positive mucosal margin, postoperative systemic therapy/RT </span>
<span id="t2a_169" class="t s4_169">(category 1) is the recommended treatment. For patients with positive or </span>
<span id="t2b_169" class="t s4_169">close margins, re-resection is preferred if feasible. If not, RT is an option </span>
<span id="t2c_169" class="t s4_169">for these patients, and systemic therapy/RT may be considered. For </span>
<span id="t2d_169" class="t s4_169">patients with other risk features, options include RT or to consider </span>
<span id="t2e_169" class="t s4_169">systemic therapy/RT. </span>
<span id="t2f_169" class="t s4_169">Surgery is preferred for locally advanced disease. For patients with </span>
<span id="t2g_169" class="t s4_169">advanced-stage, resected oral cavity cancers who have the adverse </span>
<span id="t2h_169" class="t s4_169">pathologic features of extranodal extension with or without a positive </span>
<span id="t2i_169" class="t s4_169">mucosal margin, the recommended postoperative adjuvant treatment is </span>
<span id="t2j_169" class="t s4_169">systemic therapy/RT (category 1). </span>
<span id="t2k_169" class="t s5_169">134-137,139 </span>
<span id="t2l_169" class="t s4_169">Adjuvant treatment options for </span>
<span id="t2m_169" class="t s7_169">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
